Prenatal diagnosis of SLC25A24 Fontaine progeroid syndrome: description of the fetal phenotype, genotype and detection of parental mosaicism.
2D/3D ultrasound
Fontaine progeroid syndrome
SLC25A24
craniofacial dysostosis
dysmorphic facial features
fetal growth restriction
fetus
mitochondrial disease
mosaicism
Journal
Birth defects research
ISSN: 2472-1727
Titre abrégé: Birth Defects Res
Pays: United States
ID NLM: 101701004
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
revised:
05
05
2024
received:
22
06
2023
accepted:
23
06
2024
medline:
9
7
2024
pubmed:
9
7
2024
entrez:
9
7
2024
Statut:
ppublish
Résumé
Fontaine progeroid syndrome (FPS, OMIM 612289) is a recently identified genetic disorder stemming from pathogenic variants in the SLC25A24 gene, encoding a mitochondrial carrier protein. It encompasses Gorlin-Chaudry-Moss syndrome and Fontaine-Farriaux syndrome, primarily manifesting as craniosynostosis with brachycephaly, distinctive dysmorphic facial features, hypertrichosis, severe prenatal and postnatal growth restriction, limb shortening, and early aging with characteristic skin changes, phalangeal anomalies, and genital malformations. All known occurrences of FPS have been postnatally observed until now. Here, we present the first two prenatal cases identified during the second trimester of pregnancy. While affirming the presence of most postnatal abnormalities in prenatal cases, we note the absence of a progeroid appearance in young fetuses. Notably, our reports introduce new phenotypic features like encephalocele and nephromegaly, which were previously unseen postnatally. Moreover, paternal SLC25A24 mosaicism was detected in one case. We present the initial two fetal instances of FPS, complemented by thorough phenotypic and genetic assessments. Our findings expand the phenotypical spectrum of FPS, unveiling new fetal phenotypic characteristics. Furthermore, one case underscores a potential novel inheritance pattern in this disorder. Lastly, our observations emphasize the efficacy of exome/genome sequencing in both prenatal and postmortem diagnosis of rare polymalformative syndromes with a normal karyotype and array-based comparative genomic hybridization (CGH).
Sections du résumé
BACKGROUND
BACKGROUND
Fontaine progeroid syndrome (FPS, OMIM 612289) is a recently identified genetic disorder stemming from pathogenic variants in the SLC25A24 gene, encoding a mitochondrial carrier protein. It encompasses Gorlin-Chaudry-Moss syndrome and Fontaine-Farriaux syndrome, primarily manifesting as craniosynostosis with brachycephaly, distinctive dysmorphic facial features, hypertrichosis, severe prenatal and postnatal growth restriction, limb shortening, and early aging with characteristic skin changes, phalangeal anomalies, and genital malformations.
CASES
METHODS
All known occurrences of FPS have been postnatally observed until now. Here, we present the first two prenatal cases identified during the second trimester of pregnancy. While affirming the presence of most postnatal abnormalities in prenatal cases, we note the absence of a progeroid appearance in young fetuses. Notably, our reports introduce new phenotypic features like encephalocele and nephromegaly, which were previously unseen postnatally. Moreover, paternal SLC25A24 mosaicism was detected in one case.
CONCLUSIONS
CONCLUSIONS
We present the initial two fetal instances of FPS, complemented by thorough phenotypic and genetic assessments. Our findings expand the phenotypical spectrum of FPS, unveiling new fetal phenotypic characteristics. Furthermore, one case underscores a potential novel inheritance pattern in this disorder. Lastly, our observations emphasize the efficacy of exome/genome sequencing in both prenatal and postmortem diagnosis of rare polymalformative syndromes with a normal karyotype and array-based comparative genomic hybridization (CGH).
Substances chimiques
SLC25A24 protein, human
0
Mitochondrial Proteins
0
Calcium-Binding Proteins
0
Antiporters
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2380Informations de copyright
© 2024 The Author(s). Birth Defects Research published by Wiley Periodicals LLC.
Références
Castori, M., Silvestri, E., Pedace, L., Marseglia, G., Tempera, A., Antigoni, I., Torricelli, F., Majore, S., & Grammatico, P. (2009). Fontaine–Farriaux syndrome: a recognizable craniosynostosis syndrome with nail, skeletal, abdominal, and central nervous system anomalies. American Journal of Medical Genetics, 149A(10), 2193–2199.
Dall'Asta, A., Paramasivam, G., Lees, C., Ghi, T., & Frusca, T. (2019). The brain shadowing sign: a clue finding for early suspicion of craniosynostosis? Fetal Diagnosis & Therapy, 45(5), 357–360.
Del Arco, A., & Satrústegui, J. (2004). Identification of a novel human subfamily of mitochondrial carriers with calcium‐binding domains. The Journal of Biological Chemistry, 279(23), 24701‐13.
Delahaye, S., Bernard, J.‐P., Rénier, D., & Ville, Y. (2003). Prenatal ultrasound diagnosis of fetal craniosynostosis. Ultrasound Obstetrics & Gynecology, 21(4), 347–353.
Ehmke, N., Graul‐Neumann, L., Smorag, L., Koenig, R., Segebrecht, L., Magoulas, P., Scaglia, F., Kilic, E., Henning, A. F., Adolphs, N., Saha, N., Fauler, B., Kalscheuer, V. M., Hennig, F., Altmüller, J., Netzer, C., Thiele, H., Nürnberg, P., Yigit, G., … Kornak, U. (2017). De novo mutations in SLC25A24 cause a craniosynostosis syndrome with hypertrichosis, progeroid appearance, and mitochondrial dysfunction. The American Journal of Human Genetics, 101(5), 833–843.
Faro, C., Chaoui, R., Wegrzyn, P., Levaillant, J.‐M., Benoit, B., & Nicolaides, K. H. (2006). Metopic suture in fetuses with Apert syndrome at 22‐27 weeks of gestation. Ultrasound Obstetrics & Gynecology, 27(1), 28–33.
Fontaine, G., Farriaud, J.‐P., Blanckaert, D., & Lefebvre, C. (1977). A new complex polymalformative syndrome. Journal de Génétique Humaine, 25(2), 109–119.
Gorlin, R. J., Chaudhry, A. P., & Moss, M. L. (1960). Craniofacial dysostosis, patent ductus arteriosus, hypertrichosis, hypoplasia of labia majora, dental and eye anomalies ‐ a new syndrome? The Journal of Pediatrics, 56, 778–785.
Haratz, K. K., Leibovitz, Z., Svirsky, R., Leite Drummond, C., Ley, L., Gindes, L., Lerman‐Sagie, T., & Malinger, G. (2016). The ‘brain shadowing sign’: a novel marker of fetal craniosynostosis. Fetal Diagnosis Therapy, 40(4), 277–284.
Helfer, T. M., Peixoto, A. B., Tonni, G., & Araujo, E., Jr. (2016). Craniosynostosis: prenatal diagnosis by 2D/3D ultrasound, magnetic resonance imaging and computed tomography. Medical Ultrasonography, 18(3), 378–385.
Ippel, P. F., Gorlin, R. J., Lenz, W., van Doorrne, J. M., & Bijlsma, J. B. (1992). Craniofacial dysostosis, hypertrichosis, genital hypoplasia, ocular, dental and digit defects: confirmation of the Gorlin–Chaudhry–Moss syndrome. American Journal of Medical Genetics, 44(4), 518–522.
Legué, J., François, J. H. M., van Rijswijk, C. S. P., & van Brakel, T. J. (2020). Is Gorlin–Chaudhry–Moss syndrome associated with aortopathy? Eur J Cardiothorac Surg, 58, 654–655.
Palmieri, F., Scarcia, P., & Monné, M. (2020). Diseases caused by mutations in mitochondrial carrier genes SLC25: a review. Biomolecules, 10(4), 655–687.
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier‐Foster, J., Grody, W. W., Hedge, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., & ACMG Laboratory Quality Assurance Committee. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17, 405424.
Rodríguez‐García, M.‐E., Cotrina‐Vinagre, F.‐J., Cruz‐Rojo, J., Garzón‐Lorenzo, L., Carnicero‐ Rodríguez, P., Sánchez‐Del Pozo, J., & Martínez‐Azorín, F. (2018). A rare male patient with Fontaine progeroid syndrome caused by p.R217H de novo mutation in SLC25A24. American Journal of Medical Genetics, 176A, 2479–2486.
Ryu, J., Ko, J. M., & Shin, C.‐H. (2019). A 9‐year‐old Korean girl with Fontaine progeroid syndrome: a case report with further phenotypical delineation and description of clinical course during long‐term follow‐up. BMC Medical Genetics, 20, 188–195.
Symonds, M. E., Pope, M., Sharkey, D., & Budge, H. (2012). Adipose tissue and fetal programming. Diabetologia, 55, 1597–1606.
Urano, T., Shiraki, M., Sasaki, N., Ouchi, Y., & Inoue, S. (2015). SLC25A24 as a novel susceptibility gene for low fat mass in humans and mice. The Journal of Clinical Endocrinology & Metabolism, 100(4), E655–E663.
Velasco, D., Olney, A. H., & Starr, L. (2022). SLC25A24 fontaine progeroid syndrome. In Gene Reviews®. University of Washington.
Writzl, K., Maver, A., Kovačič, L., Martinez‐Valero, P., Contreras, L., Satrústegui, J., Castori, M., Faivre, L., Lapunzina, P., van Kuilenburg, A. B. P., Radović, S., Thauvin‐Robinet, C., Peterlin, B., del Arco, A., & Hennekam, R. C. (2017). De novo mutations in SLC25A24 cause a disorder characterized by early aging, bone dysplasia, characteristic face, and early demise. The American Journal of Human Genetics, 101(5), 844–855.